RZLT
#3020
Rezolute, Inc. - Common Stock
4.5 8 USD
+0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+1.78%
Changement Mensuel
+0.88%
Evolution sur 6 mois
+52.67%
Changement Annuel
-36.12%
Clôture Précédente
4.5 0
Open
4.5 3
Low
4.5 1
High
4.5 8
Volume
469
Financials
- Market Capitalization 441.02 M
- Employee 71
- Founded 2010
- CEO N/A
- Website www.rezolutebio.com
- Headquarter Nevada, United States
- FIGI BBG001XWWHL4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.67
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3007 |  BNTC Benitec Biopharma Inc. - Common Stock | 12.88 USD | +4.63% | 0.00% | +8.51% | -22.46% | 442.48 M USD | ||
| 3014 |  CMPX Compass Therapeutics, Inc. - Common Stock | 2.44 USD | +5.63% | +0.41% | +25.77% | -28.86% | 439.41 M USD | ||
| 3028 |  FENC Fennec Pharmaceuticals Inc. - Common Stock | 12.32 USD | +2.41% | +1.23% | +27.80% | +37.65% | 432.03 M USD | ||
| 3046 |  RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 3.86 USD | +3.49% | +5.46% | +23.32% | +20.25% | 423.73 M USD |